Is odevixibat available in Japan and what is the price difference?

Odevixibat, a targeted drug used to treat hereditary cholestatic diseases in children and adults, has variable availability worldwide. According to current public information, odexibat has been approved in Japan, but the specific accessibility, launch time and sales channels in the Japanese market have not yet been fully disclosed. Therefore, if domestic patients want to obtain the drug through Japanese channels, they need to go through regular overseas drug purchase channels and follow local drug import and use regulations.

In terms of price, the original drug price of odexibat in the Japanese market is usually higher. Taking overseas markets as a reference, the price of the original drug with a specification of 200mcg*30 tablets may be as high as more than 40,000 yuan. The actual price may fluctuate due to factors such as exchange rates and import taxes. This makes it more expensive for domestic patients to purchase original drugs through Japanese channels, and logistics and customs policy restrictions also need to be considered.

In comparison, the price of the generic drug odexibat already on the market in Laos is more affordable. Take the 400mcg 30-capsule generic drug of Ordesibat produced by Lucius in Laos as an example. The price per box is about RMB 3,000, while the price of the 200mcg30-capsule or 1200mcg*30-capsule generic drug produced by ASEAN Pharmaceuticals in Laos is even lower, only around RMB 500. The ingredients of generic drugs are basically the same as those of original drugs, which can reduce the financial burden on patients to a certain extent.
Generally speaking, although odexibat is theoretically available for purchase in Japan, the price is high and the channels are limited; relatively speaking, Laotian generic drugs have obvious advantages in price, and the drug ingredients are consistent with the original drugs. When choosing a way to purchase drugs, patients need to comprehensively consider factors such as price, legality, drug quality, and logistics time, and should use drugs rationally under the guidance of professional doctors to ensure the safety and effectiveness of treatment.
Reference link: https://www.drugs.com